TAT and hypertensive disorder: The results illustrated that NHT and HTN can act as Tat antagonists by binding to TAR RNA and P-TEFb and reduce the infectivity of the progeny virus by inhibiting the vRNA packaging, thereby highlighting their potential for development as effective treatments that regulate multiple steps in the HIV-1 life cycle.